In the wake of a Federal Trade Commission investigation into hospital group Renown Health, following a law firm’s own review of the group’s buyout of a cardiology practice, the Nevada-based business’s CEO and three other executives have resigned. Renown CEO Jim Miller has stepped down from his position after agreeing with the FTC to release 10 cardiologists from the practice the company acquired from non-compete agreements. The group additionally paid $4.2 million to a dozen cardiologists. Renown has acknowledged the antitrust probe as the reason for the CEO’s resignation; a press release from the group’s board chairman noted that “things did not go as planned” concerning the acquisition. He added, “If the execution of the SNCA transaction had been as solid as our intentions, none of this would have occurred.” SCNA, or Sierra Nevada Cardiology Associates, was acquired by Renown in March 2011.
Featured News
Draft Budget Bills Would Slash Trump Administration’s Tech-Funding Requests
Jan 14, 2026 by
CPI
Shadow AI Emerges as the New Front Line in GenAI Compliance
Jan 14, 2026 by
CPI
Google Asks Judge to Reject Media Company Claims Over AI Search Overviews
Jan 14, 2026 by
CPI
China Launches Antitrust Probe Into Trip.com Over Market Practices
Jan 14, 2026 by
CPI
Amazon to Challenge Italian Antitrust Fine Reduction in Court
Jan 14, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – CRESSE Insights
Dec 16, 2025 by
CPI
Learning from Divergence: The Role of Cross-Country Comparisons in the Evaluation of the DMA
Dec 16, 2025 by
Federico Bruni
New Regulatory Tools for the EU Foreign Direct Investment Screening and Foreign Subsidies Regulation
Dec 16, 2025 by
Ioannis Kokkoris
“Suite Dreams”: Market Definition and Complementarity in the Digital Age
Dec 16, 2025 by
Romain Bizet & Matteo Foschi
The Interaction Between Competition Policy and Consumer Protection: Institutional Design, Behavioral Insights, and Emerging Challenges in Digital Markets
Dec 16, 2025 by
Alessandra Tonazzi